For: | M’Koma AE. Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics. World J Gastrointest Surg 2014; 6(11): 208-219 [PMID: 25429322 DOI: 10.4240/wjgs.v6.i11.208] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v6/i11/208.htm |
Number | Citing Articles |
1 |
Javier P Gisbert, María Chaparro. Clinical Usefulness of Proteomics in Inflammatory Bowel Disease: A Comprehensive Review. Journal of Crohn's and Colitis 2019; 13(3): 374 doi: 10.1093/ecco-jcc/jjy158
|
2 |
Samira Pirmanesh, Nasrin Mirzaei, Masoumeh Azimirad, Abbas Yadegar, John Y. Kao, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali. A report of nonexistence of the non-Helicobacter pylori Helicobacter species in Iranian patients suffering from inflammatory bowel disease. Folia Microbiologica 2021; 66(5): 751 doi: 10.1007/s12223-021-00883-z
|
3 |
Amosy Ephreim M’Koma. Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview. Medicina 2022; 58(5): 567 doi: 10.3390/medicina58050567
|
4 |
Kyeong Seob Shin, Jonghwa Yum. Applications of MALDI-TOF Mass Spectrometry in Clinical Microbiology. Biomedical Science Letters 2022; 28(3): 145 doi: 10.15616/BSL.2022.28.3.145
|
5 |
Chrysanthi Skevaki, Jolice Van den Berg, Nicholas Jones, Johan Garssen, Peter Vuillermin, Michael Levin, Alan Landay, Harald Renz, Philip C. Calder, Catherine A. Thornton. Immune biomarkers in the spectrum of childhood noncommunicable diseases. Journal of Allergy and Clinical Immunology 2016; 137(5): 1302 doi: 10.1016/j.jaci.2016.03.012
|
6 |
Amanda D. Williams, Olga Y. Korolkova, Amos M. Sakwe, Timothy M. Geiger, Samuel D. James, Roberta L. Muldoon, Alan J. Herline, J. Shawn Goodwin, Michael G. Izban, Mary K. Washington, Duane T. Smoot, Billy R. Ballard, Maria Gazouli, Amosy E. M'Koma, Shree Ram Singh. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease. PLOS ONE 2017; 12(8): e0179710 doi: 10.1371/journal.pone.0179710
|
7 |
Laila Aldars-García, Javier P. Gisbert, María Chaparro. Metabolomics Insights into Inflammatory Bowel Disease: A Comprehensive Review. Pharmaceuticals 2021; 14(11): 1190 doi: 10.3390/ph14111190
|
8 |
Laila Aldars-García, Rubén Gil-Redondo, Nieves Embade, Sabino Riestra, Montserrat Rivero, Ana Gutiérrez, Iago Rodríguez-Lago, Luis Fernández-Salazar, Daniel Ceballos, José Manuel Benítez, Mariam Aguas, Iria Baston-Rey, Fernando Bermejo, María José Casanova, Rufo Lorente, Yolanda Ber, Daniel Ginard, María Esteve, Ruth de Francisco, María José García, Rubén Francés, Ainhoa Rodríguez Pescador, Benito Velayos, Elena Guerra del Río, Sandra Marín Pedrosa, Alejandro Minguez Sabater, Manuel Barreiro-de Acosta, Alicia Algaba, Cristina Verdejo Gil, Olga Rivas, Vanesa Royo, Montserrat Aceituno, Ana Garre, Montserrat Baldán-Martín, Cristina Ramírez, Ancor Sanz-García, Juan J Lozano, Julia Sidorova, Oscar Millet, David Bernardo, Javier P Gisbert, María Chaparro. Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases 2024; 30(2): 167 doi: 10.1093/ibd/izad154
|
9 |
Amosy E. M’Koma. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. Gastrointestinal Disorders 2018; 1(1): 75 doi: 10.3390/gidisord1010007
|
10 |
Joseph Diab, Terkel Hansen, Rasmus Goll, Hans Stenlund, Maria Ahnlund, Einar Jensen, Thomas Moritz, Jon Florholmen, Guro Forsdahl. Lipidomics in Ulcerative Colitis Reveal Alteration in Mucosal Lipid Composition Associated With the Disease State. Inflammatory Bowel Diseases 2019; 25(11): 1780 doi: 10.1093/ibd/izz098
|